The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
paeonol inhibits the reaction [Epirubicin results in decreased phosphorylation of AKT1 protein] [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of AKT1 mRNA; [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of and results in decreased phosphorylation of AKT1 protein; paeonol inhibits the reaction [Epirubicin results in increased phosphorylation of AKT1 protein]
paeonol inhibits the reaction [Epirubicin results in decreased expression of BCL2 protein] [Doxorubicin co-treated with paeonol] results in increased expression of BCL2 mRNA
paeonol inhibits the reaction [Epirubicin results in increased cleavage of CASP3 protein] paeonol inhibits the reaction [Indomethacin results in increased expression of CASP3 mRNA]
[paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]] which affects the localization of NFKB1 protein; [paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]] which affects the localization of RELA protein; paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of [CHUK protein binds to IKBKB protein]]
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of and results in decreased phosphorylation of EGFR protein; [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of EGFR mRNA
[paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]] which affects the localization of NFKB1 protein; [paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]] which affects the localization of RELA protein; paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of [CHUK protein binds to IKBKB protein]]
paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL1B mRNA]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL1B protein]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of IL1B protein] [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased secretion of IL1B protein; paeonol inhibits the reaction [Indomethacin results in increased expression of IL1B mRNA]
paeonol inhibits the reaction [Epirubicin results in increased expression of IL2 mRNA]; paeonol inhibits the reaction [Epirubicin results in increased expression of IL2 protein]
paeonol inhibits the reaction [Epirubicin results in increased expression of IL6 mRNA]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 mRNA]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 protein]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of IL6 protein] [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased secretion of IL6 protein
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] affects the secretion of MMP9 protein
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of and results in decreased phosphorylation of MTOR protein; [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of MTOR mRNA; paeonol inhibits the reaction [Epirubicin results in increased phosphorylation of MTOR protein]
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of MUC5AC mRNA; [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased secretion of MUC5AC protein
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased expression of MUC5B mRNA
[paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]] which affects the localization of NFKB1 protein; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 affects the localization of NFKB1 protein]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of NFKB1 protein]
[paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]] which affects the localization of NFKB1 protein; [paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]] which affects the localization of RELA protein; paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in decreased expression of NFKBIA protein] paeonol inhibits the reaction [Epirubicin results in decreased expression of and results in increased phosphorylation of NFKBIA protein]
paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of NOS2 mRNA]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of NOS2 protein]
paeonol results in increased expression of NOTCH1 mRNA paeonol affects the reaction [Doxorubicin results in decreased expression of NOTCH1 mRNA] paeonol results in increased cleavage of NOTCH1 protein
paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of PTGS2 mRNA]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of PTGS2 protein]
[paeonol inhibits the reaction [[CHUK protein binds to IKBKB protein] which results in increased degradation of NFKBIA protein]] which affects the localization of RELA protein; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 affects the localization of RELA protein]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of RELA protein] paeonol inhibits the reaction [Epirubicin results in increased phosphorylation of RELA protein]; paeonol inhibits the reaction [Indomethacin results in increased expression of RELA mRNA]
[paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] affects the secretion of TIMP1 protein
paeonol inhibits the reaction [Epirubicin results in increased expression of TNF mRNA]; paeonol inhibits the reaction [Epirubicin results in increased expression of TNF protein]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of TNF mRNA]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of TNF protein]; paeonol inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein] [paeonol co-treated with icariin co-treated with nobiletin co-treated with Ginsenosides co-treated with astragaloside A] results in decreased secretion of TNF protein
browse the term
